IL-7 drug substance, IL7 comprising composition, preparation and uses thereof

Details for Australian Patent Application No. 2003250216 (hide)

Owner Cytheris

Inventors Assouline, Brigitte; Gregoire, Anne; Morre, Michel Christian; Cortez, Pierre

Agent Pizzeys

Pub. Number AU-B-2003250216

PCT Number PCT/EP03/08701

PCT Pub. Number WO2004/018681

Priority 02291996.3 08.08.02 EP; 60/475,881 05.06.03 US

Filing date 6 August 2003

Wipo publication date 11 March 2004

Acceptance publication date 5 August 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/002 (2006.01) Medicinal preparations containing antigens or antibodies - Protozoa antigens

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61K 39/118 (2006.01) Medicinal preparations containing antigens or antibodies - Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/245 (2006.01) Medicinal preparations containing antigens or antibodies - Herpetoviridae, e.g. herpes simplex virus

A61K 39/25 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 02291996.3 08.08.02 EP; 60/475,881 05.06.03 US

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003250216

5 August 2010 Application Accepted

  Published as AU-B-2003250216

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003250217-GPI ANCHORED GLYCOPROTEIN ACA AS A NOVEL TUMOR MARKER

2003250215-N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion